Table 6 Follow-up outcomes
Variables | Group A (n = 40) | Group B (n = 40) | Group C (n = 39) | P values▲ |
|---|---|---|---|---|
Resting VAS | ||||
2 weeks | 0.2 ± 0.4 | 0.2 ± 0.4 | 0.3 ± 0.4 | 0.839 |
3 months | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.999 |
6 months | 0.1 ± 0.3 | 0.1 ± 0.2 | 0.1 ± 0.3 | 0.704 |
Movement VAS | ||||
2 weeks | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.3 ± 0.4 | 0.932 |
3 months | 0.7 ± 0.7 | 0.7 ± 0.6 | 0.7 ± 0.7 | 0.991 |
6 months | 0.6 ± 0.6 | 0.5 ± 0.6 | 0.6 ± 0.6 | 0.578 |
HOOS-3 months | ||||
Symptoms | 16.6 ± 1.2 | 16.3 ± 1.1 | 16.1 ± 1.1 | 0.244 |
Pain | 31.1 ± 1.6 | 30.9 ± 1.5 | 30.5 ± 1.7 | 0.238 |
Daily living | 60.9 ± 1.7 | 61.3 ± 1.9 | 60.7 ± 1.7 | 0.420 |
Sports and recreational activities | 12.0 ± 1.5 | 12.5 ± 1.4 | 11.9 ± 1.4 | 0.153 |
Quality of life | 11.8 ± 1.3 | 12.0 ± 1.3 | 11.7 ± 1.2 | 0.455 |
HHS-3 months | 89.1 ± 2.2 | 88.7 ± 2.3 | 88.2 ± 2.1 | 0.213 |
SF-12-3 months | ||||
PCS | 22.3 ± 1.1 | 21.8 ± 1.3 | 22.0 ± 1.2 | 0.274 |
MCS | 26.1 ± 1.3 | 26.0 ± 1.3 | 25.9 ± 1.4 | 0.737 |
HOOS-6 months | ||||
Symptoms | 16.9 ± 0.9 | 17.1 ± 0.8 | 16.9 ± 0.8 | 0.467 |
Pain | 34.2 ± 1.8 | 33.9 ± 1.4 | 33.6 ± 1.3 | 0.336 |
Daily living | 63.5 ± 1.4 | 63.1 ± 1.7 | 63.1 ± 1.5 | 0.396 |
Sports and recreational activities | 13.0 ± 1.0 | 13.0 ± 1.1 | 12.7 ± 1.1 | 0.301 |
Quality of life | 13.0 ± 1.1 | 12.9 ± 1.0 | 12.6 ± 0.7 | 0.193 |
HHS-6 months | 92.1 ± 1.9 | 92.6 ± 2.2 | 92.0 ± 2.0 | 0.285 |
SF-12-6 months | ||||
PCS | 23.2 ± 1.1 | 23.3 ± 1.0 | 23.0 ± 0.8 | 0.291 |
MCS | 27.0 ± 0.9 | 27.4 ± 1.1 | 27.0 ± 0.9 | 0.092 |